Presented for research literature review only Isobe Y et al
Along with blood sugar spikes, when you stop taking a GLP-1 medication, you will likely experience an increase in hunger and cravings
This peptide pairing is different because the research value comes from how two peptide mechanisms are examined within the same laboratory model
Although there is an active search for effective treatments of HF, up to 50% of diagnosed patients have died in the past 30 years, indicating that the pathogenesis of this disease has not yet been fully elucidated (90)
"Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society." The American journal of clinical nutrition 122.1 (2025): 344-367
Research indicates that VEGF levels in the serum of patients with DR progressively rise as the disease worsens, highlighting its critical role in the development of DR and its correlation with disease severity